Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCDRecruiting
NCT05431088Phase 2, Phase 3Updated Aug 18, 2026
Sponsor: Pfizer
Sickle Cell Disease
United States, Brazil, India, Kenya, Nigeria +2 more
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung CancerRecruiting
NCT07476287Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Small Cell Lung Cancer · Small Cell Lung Cancer ( SCLC ) · Transformed Small Cell Lung Cancer · Lung Neoplasms
United States, Brazil, China, France, Hong Kong +5 more
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe EczemaRecruiting
NCT06807281Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Atopic Dermatitis
United States, China, Germany, Hungary, Japan +3 more
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial CancerRecruiting
NCT07421700Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Urothelial Cancer · Advanced/Metastatic Urothelial Cancer · Urothelial Carcinoma
United States, Australia, China, Japan, Puerto Rico +1 more
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruiting
NCT07222566Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Brazil, Canada +15 more
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or ObesityCompleted
NCT07400679Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
Overweight · Obesity · Healthy
United States
A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in JapanActive Not Recruiting
NCT06864585N/AUpdated Aug 17, 2026
Sponsor: Pfizer
Infectious Diseases
Japan
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCActive Not Recruiting
NCT03395197Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
mCRPC
United States, Argentina, Australia, Belgium, Brazil +21 more
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerRecruiting
NCT07222800Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Intestinal Neoplasms · Gastrointestinal Neoplasms · Digestive System Neoplasms · Neoplasms by Site
United States, Argentina, Australia, Belgium, Brazil +12 more
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruiting
NCT07595549Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Obesity · Overweight and/or Obesity · Overweight
United States, Brazil, Canada, Japan
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerRecruiting
NCT07206225Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
Non-muscle Invasive Bladder Cancer
United States, France, Israel, South Korea, Spain +1 more
A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised AdultsNot Yet Recruiting
NCT07768345Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Respiratory Syncytial Virus (RSV)
United States
A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19Terminated
NCT05386472Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
COVID-19
United States
A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaRecruiting
NCT07216027Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Atopic Dermatitis · Eczema, Atopic
United States, Canada, China, Japan
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerRecruiting
NCT06952660Phase 4Updated Aug 17, 2026
Sponsor: Pfizer
Cervical Cancer
United States, Puerto Rico
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced CancersRecruiting
NCT07426757Phase 1Updated Aug 17, 2026
Sponsor: Pfizer
Advanced Malignancies · Advanced Cancer
United States, Canada
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.Recruiting
NCT06899204N/AUpdated Aug 17, 2026
Sponsor: Pfizer
Atopic Dermatitis · Atopic Dermatitis, Unspecified · Dermatitis, Atopic
United States
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial CancerNot Yet Recruiting
NCT07578649Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Endometrial Neoplasms · Endometrial Cancer
Japan
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung CancerRecruiting
NCT07226999Phase 2, Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Small Cell Lung Cancer (SCLC)
United States, Australia, China, France, Germany +5 more
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Recruiting
NCT07144280Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
A Study to Learn About the Safety of PENBRAYA During PregnancyRecruiting
NCT07768163N/AUpdated Aug 17, 2026
Sponsor: Pfizer
Meningococcal Disease
United States
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)Recruiting
NCT07575932Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Overweight · Obesity · Overweight and/or Obesity · Overweight or Obesity
United States, Canada
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCActive Not Recruiting
NCT04821622Phase 3Updated Aug 17, 2026
Sponsor: Pfizer
Prostate Cancer
United States, Argentina, Australia, Belgium, Bulgaria +22 more
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLCRecruiting
NCT07489066Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Carcinoma · Non-Small-Cell Lung · Lung Cancer (NSCLC) · Lung Neoplasms
United States, China, Israel, Puerto Rico, Taiwan
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.Recruiting
NCT07227012Phase 1, Phase 2Updated Aug 17, 2026
Sponsor: Pfizer
Carcinoma, Hepatocellular · Hepatocellular Cancer · Hepatocellular Carcinoma · Unresectable Hepatocellular Carcinoma
United States, Japan, Puerto Rico, Taiwan

Previous page Next page